Skip to main content
BioInfra Life Science Inc. logo

BioInfra Life Science Inc. — Investor Relations & Filings

Ticker · 266470 ISIN · KR7266470004 KO Professional, scientific and technical activities
Open in API
Filings indexed 120 across all filing types
Latest filing 2025-03-31 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 266470

About BioInfra Life Science Inc.

http://bioinfra.co.kr/?lang=en

BioInfra Life Science Inc. is a biotechnology company focused on cancer prevention, early detection, and treatment. The company's core technology is a multi-biomarker blood test, an in-vitro diagnostic solution designed for the early screening of eight major cancers, including lung, liver, stomach, colorectal, prostate, breast, pancreatic, and ovarian cancer. This test analyzes cancer risk from a small blood sample. In addition to its diagnostic platform, the company develops cancer gene treatments and technologies to monitor the potential for metastasis and recurrence, aiming to provide innovative solutions in the healthcare field.

Recent filings

Filing Released Lang Actions
주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on the Granting of Stock Options). It details the issuance of stock options to directors and employees, including the number of shares, exercise price, and vesting conditions. In the context of Korean corporate filings (DART system), this is a specific regulatory disclosure regarding stock option grants, which falls under the category of 'Regulatory Filings' (RNS) as it does not fit into specific categories like 'Director's Dealing' (which usually refers to trading of existing shares) or 'Share Issue' (which refers to capital changes).
2025-03-31 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a short regulatory filing (1385 characters) titled '감사보고서 제출' (Submission of Audit Report). It provides a summary table of audit opinions and key financial figures, and explicitly states that the audit report has been received on 2025-03-21. According to the 'Menu vs Meal' rule, since this is a short announcement regarding the submission of an audit report rather than the full audit report document itself, it is classified as a Report Publication Announcement (RPA). FY 2024
2025-03-21 Korean
사업보고서 (2024.12)
Annual Report Classification · 100% confidence The document is a 'Business Report' (사업보고서) for the 24th fiscal year (2024-01-01 to 2024-12-31) for BioInfra Life Science Inc. It contains detailed company information, history, capital structure, business operations, and financial data. In the context of Korean corporate filings, the 'Business Report' (사업보고서) is the equivalent of the annual comprehensive financial and operational report, which corresponds to the 10-K filing type. FY 2024
2025-03-21 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for Bioinfra Life Science. It contains the agenda for the 24th Annual General Meeting, including the approval of financial statements, election of directors, and other corporate governance matters. This type of document is sent to shareholders to provide information and request votes for the upcoming meeting, which fits the definition of a Proxy Solicitation & Information Statement.
2025-03-13 Korean
주주총회소집결의
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집 결의) issued by Bioinfra Life Science. It outlines the date, location, and agenda items for the upcoming Annual General Meeting (AGM), including the approval of financial statements, election of directors, and remuneration limits. This document serves as the official proxy solicitation and information statement provided to shareholders to inform them of the meeting and request their participation/votes. Therefore, it is classified as a Proxy Solicitation & Information Statement (PSI).
2025-02-28 Korean
불성실공시법인지정 (공시불이행)
Regulatory Filings Classification · 100% confidence The document is a formal regulatory notice regarding the designation of the company as an 'unfaithful disclosure corporation' (불성실공시법인) due to non-compliance with disclosure requirements (공시불이행) related to a capital increase decision. This is a regulatory announcement concerning legal/compliance status and does not fit into specific categories like financial reports or shareholder meetings. Therefore, it is classified as a Regulatory Filing (RNS).
2024-12-20 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.